USANA Health Sciences Past Earnings Performance
Past criteria checks 1/6
USANA Health Sciences's earnings have been declining at an average annual rate of -15.6%, while the Personal Products industry saw earnings growing at 9.3% annually. Revenues have been declining at an average rate of 5% per year. USANA Health Sciences's return on equity is 10.2%, and it has net margins of 6.3%.
Key information
-15.6%
Earnings growth rate
-12.3%
EPS growth rate
| Personal Products Industry Growth | 20.9% |
| Revenue growth rate | -5.0% |
| Return on equity | 10.2% |
| Net Margin | 6.3% |
| Last Earnings Update | 28 Sep 2024 |
Recent past performance updates
Recent updates
Should You Think About Buying USANA Health Sciences, Inc. (NYSE:USNA) Now?
Dec 09
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Sep 26Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?
Sep 08USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding
Jul 17USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively
May 29USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Revenue & Expenses Breakdown
How USANA Health Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 28 Sep 24 | 862 | 54 | 615 | 0 |
| 29 Jun 24 | 875 | 55 | 623 | 0 |
| 30 Mar 24 | 900 | 62 | 638 | 0 |
| 30 Dec 23 | 921 | 64 | 651 | 0 |
| 30 Sep 23 | 928 | 60 | 656 | 0 |
| 01 Jul 23 | 948 | 63 | 667 | 0 |
| 01 Apr 23 | 974 | 65 | 682 | 0 |
| 31 Dec 22 | 999 | 69 | 697 | 0 |
| 01 Oct 22 | 1,038 | 77 | 721 | 0 |
| 02 Jul 22 | 1,079 | 89 | 740 | 0 |
| 02 Apr 22 | 1,151 | 108 | 781 | 0 |
| 01 Jan 22 | 1,186 | 117 | 798 | 0 |
| 02 Oct 21 | 1,230 | 136 | 814 | 0 |
| 03 Jul 21 | 1,254 | 139 | 828 | 0 |
| 03 Apr 21 | 1,176 | 129 | 774 | 0 |
| 02 Jan 21 | 1,135 | 125 | 749 | 0 |
| 26 Sep 20 | 1,095 | 116 | 730 | 0 |
| 27 Jun 20 | 1,058 | 110 | 710 | 0 |
| 28 Mar 20 | 1,055 | 103 | 717 | 0 |
| 28 Dec 19 | 1,061 | 101 | 727 | 0 |
| 28 Sep 19 | 1,089 | 102 | 749 | 0 |
| 29 Jun 19 | 1,125 | 109 | 771 | 0 |
| 30 Mar 19 | 1,170 | 121 | 793 | 0 |
| 29 Dec 18 | 1,189 | 126 | 800 | 0 |
| 29 Sep 18 | 1,163 | 88 | 788 | 0 |
| 30 Jun 18 | 1,128 | 81 | 772 | 0 |
| 31 Mar 18 | 1,084 | 70 | 752 | 0 |
| 30 Dec 17 | 1,047 | 63 | 735 | 0 |
| 30 Sep 17 | 1,027 | 90 | 719 | 0 |
| 01 Jul 17 | 1,020 | 97 | 709 | 0 |
| 01 Apr 17 | 1,021 | 99 | 703 | 0 |
| 31 Dec 16 | 1,006 | 100 | 687 | 0 |
| 01 Oct 16 | 986 | 102 | 670 | 0 |
| 02 Jul 16 | 965 | 98 | 651 | 0 |
| 02 Apr 16 | 940 | 97 | 630 | 0 |
| 02 Jan 16 | 918 | 95 | 617 | 0 |
| 03 Oct 15 | 914 | 92 | 618 | 0 |
| 04 Jul 15 | 872 | 86 | 591 | 0 |
| 04 Apr 15 | 827 | 80 | 561 | 0 |
| 03 Jan 15 | 790 | 77 | 534 | 0 |
| 27 Sep 14 | 749 | 76 | 499 | 0 |
| 28 Jun 14 | 731 | 73 | 484 | 0 |
| 29 Mar 14 | 731 | 78 | 481 | 0 |
| 28 Dec 13 | 718 | 79 | 474 | 0 |
Quality Earnings: USNA has high quality earnings.
Growing Profit Margin: USNA's current net profit margins (6.3%) are lower than last year (6.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: USNA's earnings have declined by 15.6% per year over the past 5 years.
Accelerating Growth: USNA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: USNA had negative earnings growth (-9.3%) over the past year, making it difficult to compare to the Personal Products industry average (-5.2%).
Return on Equity
High ROE: USNA's Return on Equity (10.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 23:17 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/28 |
| Annual Earnings | 2023/12/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
USANA Health Sciences, Inc. is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Amy Vinson | Avondale Partners |
| Scott Van Winkle | Canaccord Genuity |
| Linda Bolton-Weiser | D.A. Davidson & Co. |